2022 will mark the COVID-19 pandemic’s third year.  Since the early days of SARS-CoV-2, there have been calls to apply hard-won lessons learned from the fight against another global health crisis: HIV/AIDS. But what good are these lessons if we have yet to solve the very…

Efforts to track mutations of diseases circulating in Africa have ramped up during the COVID-19 pandemic, with health officials hoping a bolstered network of labs will serve as a sentinel for future pandemics. 

Aduhelm, Biogen’s controversial new Alzheimer’s drug, is facing more scrutiny after a

All the talk of global solidarity in the face of COVID-19 rings hollow. International medical partners who evacuated left Ugandans under-equipped and alone, according to a trio of Ugandan researchers from Mbarara University of Science and Technology and Makere University…

A new study that found SARS-CoV-2 spreading quickly through the white-tailed deer population in the middle of the US spells bad news for any hopes of eliminating the virus.  

When ProPublica investigated an outbreak of a multidrug-resistant salmonella called infantis that has sickened tens of thousands of people in the US, it deployed the usual “bread and butter” interviews and public records requests. It also rolled out a novel tool: genomic…

South African government scientists spent years on a study tracking the health toll of the world’s fifth largest coal industry. The damning results are yet to be published.   Among the findings: In the nation’s coal belt, 5,000 South Africans die every year…

Back in 2017, scientists discovered a coronavirus causing mild illness in health workers in Haiti—it’s 99.4% identical to one discovered 11,000 miles away in Malaysia in May that probably jumped from dogs to people, according to a Clinical Infectious Diseases study.  

African scientists are working hard to test new drugs against COVID-19 that would also be affordable, but they are running into significant challenges, Nature reports.   Why new drugs are needed:

2 Ecuadorian scientists face 10–13 years in prison after being embroiled in a criminal case involving Quito’s purchase of allegedly sub-par COVID-19 tests.   Scientists and universities have come out in defense of molecular biologist Linda Guamán and public health scientist…